Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Riverbank Capital Securities

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 3
Average round size
info
The average size of a deal this fund participated in
$12M
Portfolio companies 2
Rounds per year 0.18
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.33
Key employees 1
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Health Care
  • Pharmaceutical
  • Biotechnology
Summary

Riverbank Capital Securities is the famous VC, which was founded in 2012. The leading representative office of defined VC is situated in the New York. The venture was found in North America in United States.

This Riverbank Capital Securities works on 4 percentage points more the average amount of lead investments comparing to the other organizations. The top amount of exits for fund were in 2014. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year. The top activity for fund was in 2007.

For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Kite Pharma, Tigris Pharmaceuticals. The fund has no exact preference in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most successful fund investment fields, there are Pharmaceutical, Medical.

The overall number of key employees were 1.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Riverbank Capital Securities, startups are often financed by Wexford Capital, NGN Capital. The meaningful sponsors for the fund in investment in the same round are Wexford Capital, Two River, Sonostar Capital Partners. In the next rounds fund is usually obtained by Two River, Sonostar Capital Partners, Arie Belldegrun.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Riverbank Capital Securities:
Typical Co-investors
Riverbank Capital Securities is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Riverbank Capital Securities:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
1UP -
Alchemist Blockchain Techstars Accelerator New York, New York, United States
AxVentures-Pymar Fund Argentina, Buenos Aires, Distrito Federal
Bengo 4.com Chiba Prefecture, Japan, Tateyama
BlackEarth Ventures -
Brohuvudet -
ETP Ventures -
Groupe Revue Fiduciaire -
Hakuhodo Chiba, Japan, Minato
Human Genome Sciences Maryland, Rockville, United States
Kingston California, Fountain Valley, United States
Legendary Ventures New York, New York, United States
MedStar Health Columbia, Maryland, United States
Residence Ventures New York, New York, United States
Sparkle Roll Group China, Hong Kong, Hong Kong Island
Teachers' Merchant Bank -
The Grover Trust -
Vista Credit Partners -
Women's Health USA Avon, Connecticut, United States
Xizang Langrun Chengguan District, China, Lhasa

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Kite Pharma

$15M09 Mar 2011 -

Biotechnology
Health Care
Pharmaceutical
$6M28 Sep 2010 Florida, United States

Tigris Pharmaceuticals

Biotechnology
Health Care
Pharmaceutical
$16M17 Jan 2007 Florida, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Riverbank Capital Securities?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 3
Average round size 12M
Rounds per year 0.18
Peak activity year 2011
Lead investments 0
Follow on index 0.33
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Kite Pharma

$15M09 Mar 2011 -

Biotechnology
Health Care
Pharmaceutical
$6M28 Sep 2010 Florida, United States

Tigris Pharmaceuticals

Biotechnology
Health Care
Pharmaceutical
$16M17 Jan 2007 Florida, United States
Crunchbase icon

Content report

The following text will be sent to our editors: